Drug profile · INN
menotropins (fsh
MENOPUR
menotropins (fsh (MENOPUR) is a follicle stimulating hormone receptor agonist. Route of administration: intramuscular, subcutaneous. Current US regulatory status: approved.
Drug details — menotropins (fsh
- US status
- approved
- Class
- —
- Route
- INTRAMUSCULAR, SUBCUTANEOUS
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
menotropins (fsh (MENOPUR) is a follicle stimulating hormone receptor agonist. Route of administration: intramuscular, subcutaneous. Current US regulatory status: approved.
Key facts
Mechanism of action
Follicle stimulating hormone receptor agonist
Primary target: Follicle-stimulating hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is menotropins (fsh?
menotropins (fsh (MENOPUR) is a follicle stimulating hormone receptor agonist. Route of administration: intramuscular, subcutaneous. Current US regulatory status: approved.
What is the brand name for menotropins (fsh?
MENOPUR is a marketed brand name for menotropins (fsh. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of menotropins (fsh?
menotropins (fsh has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.